Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study
Background
The common isoforms of apolipoprotein E (apoE), E2, E3, and E4, are important determinants of plasma lipid concentrations, and the ?4 allele is associated with raised risk of coronary heart disease. We investigated whether the effect of smoking on coronary heart disease risk is affected by APOE genotype.
Methods
We enrolled 3052 middle-aged men who were free of coronary heart disease for prospective cardiovascular surveillance in the second Northwick Park Heart Study (NPHSII). Smoking habit was ascertained at baseline and yearly by questionnaire. APOE genotype was identified by PCR and restriction enzyme digestion. Endpoints were fatal coronary heart disease, non-fatal myocardial infarction, and coronary artery surgery and silent myocardial infarction at follow-up.
Findings
During 18 836 person years of surveillance, 96 men had an acute myocardial infarction, 26 needed coronary artery surgery, and 14 had silent myocardial infarctions. Compared with never-smokers, risk of coronary heart disease in ex-smokers was 1·34 (95% CI 0·86–2·08) and in smokers it was 1·94 (1·25–3·01). This risk was independent of other classic risk factors. In never-smokers, risk was closely similar in men with different genotypes. Risk in men homozygous for the ?3 allele was 1·74 (1·10–2·77) in exsmokers and 1·68 (1·01–2·83) in smokers, whereas in men carrying the ?4 allele risk was 0·84 (0·40–1·75) and 3·17 (1·82–5·50), respectively, with no significant differences in risk in the ?2 carriers. For the 3 group, the genotype effect on risk was no longer significant after adjustment for classic risk factors (including plasma lipids). However, even after adjustment, smokers who were carriers of the ?4 allele, showed significantly raised risk of coronary heart disease compared with the non-smoking group (2·79, 1·59–4·91, ·4-smoking interaction p=0·007).
Interpretation
Smoking increases the risk of coronary heart disease in men of all genotypes but particularly in men carrying the ?4 allele.
115-119
Humphries, S.E.
ccc89458-fe7c-4cce-92a3-470dac1b33b6
Talmud, P.J.
6921755a-49e5-4a12-b4b7-051c19091974
Hawe, E.
04b00658-cb75-42fc-9213-9c3ba8372105
Bolla, M.
7071a3c6-b6d1-45eb-b486-bb0ab071bc51
Day, I.N.
e9cacaf7-f4c8-4ef0-82fa-b459ad683d50
Miller, G.J.
c0be8252-47b0-4482-a977-25ac06cf59df
2001
Humphries, S.E.
ccc89458-fe7c-4cce-92a3-470dac1b33b6
Talmud, P.J.
6921755a-49e5-4a12-b4b7-051c19091974
Hawe, E.
04b00658-cb75-42fc-9213-9c3ba8372105
Bolla, M.
7071a3c6-b6d1-45eb-b486-bb0ab071bc51
Day, I.N.
e9cacaf7-f4c8-4ef0-82fa-b459ad683d50
Miller, G.J.
c0be8252-47b0-4482-a977-25ac06cf59df
Humphries, S.E., Talmud, P.J., Hawe, E., Bolla, M., Day, I.N. and Miller, G.J.
(2001)
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study.
The Lancet, 358 (9276), .
(doi:10.1016/S0140-6736(01)05330-2).
Abstract
Background
The common isoforms of apolipoprotein E (apoE), E2, E3, and E4, are important determinants of plasma lipid concentrations, and the ?4 allele is associated with raised risk of coronary heart disease. We investigated whether the effect of smoking on coronary heart disease risk is affected by APOE genotype.
Methods
We enrolled 3052 middle-aged men who were free of coronary heart disease for prospective cardiovascular surveillance in the second Northwick Park Heart Study (NPHSII). Smoking habit was ascertained at baseline and yearly by questionnaire. APOE genotype was identified by PCR and restriction enzyme digestion. Endpoints were fatal coronary heart disease, non-fatal myocardial infarction, and coronary artery surgery and silent myocardial infarction at follow-up.
Findings
During 18 836 person years of surveillance, 96 men had an acute myocardial infarction, 26 needed coronary artery surgery, and 14 had silent myocardial infarctions. Compared with never-smokers, risk of coronary heart disease in ex-smokers was 1·34 (95% CI 0·86–2·08) and in smokers it was 1·94 (1·25–3·01). This risk was independent of other classic risk factors. In never-smokers, risk was closely similar in men with different genotypes. Risk in men homozygous for the ?3 allele was 1·74 (1·10–2·77) in exsmokers and 1·68 (1·01–2·83) in smokers, whereas in men carrying the ?4 allele risk was 0·84 (0·40–1·75) and 3·17 (1·82–5·50), respectively, with no significant differences in risk in the ?2 carriers. For the 3 group, the genotype effect on risk was no longer significant after adjustment for classic risk factors (including plasma lipids). However, even after adjustment, smokers who were carriers of the ?4 allele, showed significantly raised risk of coronary heart disease compared with the non-smoking group (2·79, 1·59–4·91, ·4-smoking interaction p=0·007).
Interpretation
Smoking increases the risk of coronary heart disease in men of all genotypes but particularly in men carrying the ?4 allele.
This record has no associated files available for download.
More information
Published date: 2001
Organisations:
Human Genetics
Identifiers
Local EPrints ID: 24774
URI: http://eprints.soton.ac.uk/id/eprint/24774
ISSN: 0140-6736
PURE UUID: 1ccef17a-3af6-4db8-ad5b-2956eec10a0a
Catalogue record
Date deposited: 04 Apr 2006
Last modified: 15 Aug 2024 17:10
Export record
Altmetrics
Contributors
Author:
S.E. Humphries
Author:
P.J. Talmud
Author:
E. Hawe
Author:
M. Bolla
Author:
I.N. Day
Author:
G.J. Miller
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics